TY - JOUR
T1 - Drug-induced hair disorders.
AU - Piraccini, Bianca Maria
AU - Iorizzo, Matilde
AU - Rech, Giulia
AU - Tosti, Antonella
PY - 2006/8
Y1 - 2006/8
N2 - Drugs may induce hair loss, stimulate hair growth or, more rarely, induce changes in the hair shape and colour. Drug-induced hair loss is usually completely reversible and is, in most cases, a consequence of a toxic effect of the drug on the hair follicle matrix. In rare cases alopecia may be permanent. Depending on type of drug, dosage and patient susceptibility, hair loss presents as telogen effluvium, anagen effluvium or both. Telogen effluvium is also commonly observed after discontinuation of drugs that prolong anagen, such as topical minoxidil and oral contraceptives. Although a large number of drugs have been occasionally reported to produce hair loss, only for a few drugs the relation between drug intake and hair loss has been proven.
AB - Drugs may induce hair loss, stimulate hair growth or, more rarely, induce changes in the hair shape and colour. Drug-induced hair loss is usually completely reversible and is, in most cases, a consequence of a toxic effect of the drug on the hair follicle matrix. In rare cases alopecia may be permanent. Depending on type of drug, dosage and patient susceptibility, hair loss presents as telogen effluvium, anagen effluvium or both. Telogen effluvium is also commonly observed after discontinuation of drugs that prolong anagen, such as topical minoxidil and oral contraceptives. Although a large number of drugs have been occasionally reported to produce hair loss, only for a few drugs the relation between drug intake and hair loss has been proven.
UR - http://www.scopus.com/inward/record.url?scp=66249135714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66249135714&partnerID=8YFLogxK
U2 - 10.2174/157488606777934477
DO - 10.2174/157488606777934477
M3 - Review article
C2 - 18690941
AN - SCOPUS:66249135714
VL - 1
SP - 301
EP - 305
JO - Current Drug Safety
JF - Current Drug Safety
SN - 1574-8863
IS - 3
ER -